The Board resolution dated January 02, 2023, the BOD of DABACO Group approved contents details as follows:
- Revenue: VND24,562 billion
- Profit before tax: VND633 billion
- Profit before tax: VND569 billion.
- Name of subsidiary: Dacovet Pharmaceutical and Animal Health Company Limited
- Charter capital: VND50,000,000,000 (DABACO Group distributed 100% of Charter capital)
- Mr. Nguyen Chi Thanh as Director cum legal representative at Dacovet Pharmaceutical and Animal Health Company Limited.